Kiss Szilard 4
4 · Adverum Biotechnologies, Inc. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Kiss Szilard
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-17+21,040→ 21,040 totalExercise: $7.32Exp: 2034-06-16→ Common Stock (21,040 underlying)
Footnotes (1)
- [F1]1/3 of the total number of shares subject to the option will vest and become exercisable on each anniversary of June 17, 2024 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on each such vesting date.